Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
about
Pazopanib in the treatment of soft tissue sarcomaThe prognostic impact of TGF-β1, fascin, NF-κB and PKC-ζ expression in soft tissue sarcomas.Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft ModelsFibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcomaTargeted therapy in sarcomas other than GIST tumorsPrognostic impacts of hypoxic markers in soft tissue sarcomaTargeting protein kinases to reverse multidrug resistance in sarcoma.The VEGF- and PDGF-family of angiogenic markers have prognostic impact in soft tissue sarcomas arising in the extremities and trunk.Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes.Antiangiogenic approach in soft-tissue sarcomas.New drugs in sarcomas.The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets.Soft tissue sarcoma in the dog - Part 2: surgical margins, controversies and a comparative review.Soft tissue sarcoma in the dog - part 1: a current review.Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells.Brain derived neutrophic factor (BDNF) coordinates lympho-vascular metastasis through a fibroblast-governed paracrine axis in the tumor microenvironment.Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?[Tyrosine kinases in soft tissue tumors].Head and neck squamous cell carcinoma lymphatic spread and survival: Relevance of vascular endothelial growth factor family for tumor evaluation.
P2860
Q28269229-F8CF56A4-0C49-43CB-9DCF-0636806B9319Q33842051-0923C9CF-402D-413F-A535-0AE17F62C1E1Q35028802-E2D32C24-59EF-4BCC-83F2-3F541FC376ACQ35121634-DFCC180D-4F30-444C-9A47-C5647A776A97Q35579727-367B223F-C1CE-46B6-9D65-8C5A951A82EDQ35622367-D811D3C8-1770-4E71-AE7C-7B502416A6E7Q35789146-0EBF6540-CC7B-4A4B-B6C8-92B98887124BQ36527950-690F68B6-30DB-4E90-9FB3-9C321517D868Q37502192-A28C10FC-DF9E-4185-8C81-C18D4D989582Q38072488-09E2BBFF-43F3-4DC7-9A39-037F810A5CFBQ38128896-C03170F4-C3D2-49FC-92FD-9915317C09A5Q38165238-43A83640-6AFF-4974-92BD-C8956A7C9F14Q38252537-C741C036-F981-4115-9CFE-10D92EB28A01Q38761697-D31AE4FA-ADC7-4D6E-84FA-CBDFF2664B90Q38953742-9FE6185D-F368-4DEC-B4F1-501044E2BA44Q39281703-882F4787-9D4B-4BC2-9460-E2BD1AB3DE9AQ41683662-CB28B668-7E21-4326-91FF-71FF0AFC75B1Q53162784-E734E2B3-2A05-497B-B899-4A6B8B6ADF29Q54324690-B39D70DA-C4EB-4BAE-B73B-67292FE65328Q54352990-58085299-B419-4510-9A70-43D96EFD53AD
P2860
Profiling of VEGFs and VEGFRs as prognostic factors in soft tissue sarcoma: VEGFR-3 is an independent predictor of poor prognosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Profiling of VEGFs and VEGFRs ...... t predictor of poor prognosis.
@ast
Profiling of VEGFs and VEGFRs ...... t predictor of poor prognosis.
@en
type
label
Profiling of VEGFs and VEGFRs ...... t predictor of poor prognosis.
@ast
Profiling of VEGFs and VEGFRs ...... t predictor of poor prognosis.
@en
prefLabel
Profiling of VEGFs and VEGFRs ...... t predictor of poor prognosis.
@ast
Profiling of VEGFs and VEGFRs ...... t predictor of poor prognosis.
@en
P2093
P2860
P1433
P1476
Profiling of VEGFs and VEGFRs ...... t predictor of poor prognosis.
@en
P2093
Andrej Valkov
Eivind Smeland
Lill-Tove Busund
Roy M Bremnes
Tom Donnem
P2860
P304
P356
10.1371/JOURNAL.PONE.0015368
P407
P577
2010-12-14T00:00:00Z